The FASTER-BUP Study, Extended-Release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose: Protocol for an Observational Prospective Study ...
SAGE Journals, 2024
academicJournal
Zugriff:
North America is facing an unprecedented public health emergency of opioid-related morbidity and mortality. The mortality benefits of oral medication treatment for opioid use disorder (MOUD), such as methadone or buprenorphine, are well documented. However, barriers to access and long-term engagement have prevented maximizing their benefits. Long-acting injectable buprenorphine formulations were developed to address some of the challenges associated with oral MOUD. The “Pilot study to assess the feasibility, efficacy, and safety of extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose” (FASTER-BUP) was developed to explore this treatment option in populations at high risk of overdose in a real-world Canadian setting. FASTER-BUP is a 24-week observational prospective study evaluating the feasibility and clinical utility of extended-release injectable buprenorphine (XR-BUP) for the treatment of opioid use disorder (OUD) among 40 adults at ...
Titel: |
The FASTER-BUP Study, Extended-Release Injectable Buprenorphine for the Treatment of Opioid Use Disorder Among Individuals at High Risk of Overdose: Protocol for an Observational Prospective Study ...
|
---|---|
Autor/in / Beteiligte Person: | Langlois, Jenna ; Nolan, Seonaid ; Dickhout, Piper ; Cui, Zishan ; Paterson, Josh ; Fairbairn, Nadia ; Socías, M. Eugenia |
Link: | |
Veröffentlichung: | SAGE Journals, 2024 |
Medientyp: | academicJournal |
DOI: | 10.25384/sage.c.7039599 |
Schlagwort: |
|
Sonstiges: |
|